About Shivaxy
Shivaxy is a Healthcare company based in Bengaluru (India) founded in 2020. Shivaxy is a CDMO specializing in the manufacturing of active pharmaceutical ingredients (APIs). It operates on a B2B model. The company has 1 employees. Its Indian entity Shivaxy Pharmaceuticals Private Limited reported revenue of ₹1.97 Cr. Its focus areas include Pharmaceuticals, Contract Manufacturing and API Production. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Shivaxy, based in Bengaluru, focuses on providing healthcare solutions, producing pharmaceutical products, contract manufacturing, and api production. Shivaxy is a CDMO specializing in the manufacturing of active pharmaceutical ingredients (APIs). The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
- Headquarters Bengaluru, India
- Employees 1
- SectorsHealthcare
- Website shivaxypharma.com
- Legal Name Shivaxy Pharmaceuticals Private Limited
- Date of Incorporation 27 Jul, 2020
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹1.97 Cr
FY 2025 · -32% YoY
- Net Profit₹12.8 Lakh
FY 2025 · 7% margin
- EBITDA₹17.4 Lakh
FY 2025 · 9% margin
- Employee Count1
Associated legal entities of Shivaxy
Shivaxy operates through Shivaxy Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Shivaxy Pharmaceuticals Private Limited CIN U24299KA2020PTC136494 | Active | 27 Jul 2020 | Bangalore, Karnataka | ₹2.0 Cr | 2 | View details |
Board of directors of Shivaxy Pharmaceuticals Private Limited (Shivaxy)
Shivaxy Pharmaceuticals Private Limited is the primary company behind Shivaxy. The board of Shivaxy Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Kumari Aarti, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kumari Aarti DIN 08810058 | Director | 27 Jul 2020 | 6 yrs 3 mo | Shivaxy Pharmaceuticals Private Limited |
| Gaurav Sharma DIN 08810059 | Director | 27 Jul 2020 | 6 yrs 3 mo | Shivaxy Pharmaceuticals Private Limited |
Financials of Shivaxy
Figures of Shivaxy Pharmaceuticals Private Limited, the primary company behind Shivaxy, for FY 2025. Revenue was ₹1.97 Cr (-32% year on year). Net profit was ₹12.8 Lakh (7% margin). EBITDA was ₹17.4 Lakh (9% margin).
- ₹1.97 CrRevenue · FY 2025 · -32% YoY
- ₹12.8 LakhNet profit · 7% margin
- ₹17.4 LakhEBITDA · 9% margin
- ₹1 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Shivaxy Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Shivaxy
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Shivaxy
Shivaxy has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Shivaxy
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Shivaxy
Shivaxy was founded in 2020.
Shivaxy is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Shivaxy has 1 employees.
The primary company behind Shivaxy, Shivaxy Pharmaceuticals Private Limited, reported revenue of ₹1.97 Cr for FY 2025, down 32% year on year.
Shivaxy, based in Bengaluru, focuses on providing healthcare solutions, producing pharmaceutical products, contract manufacturing, and api production. Shivaxy is a CDMO specializing in the manufacturing of active pharmaceutical ingredients (APIs). The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Shivaxy's top competitors include Laurus Labs, Symbiotec and SeQuent.
Shivaxy operates through Shivaxy Pharmaceuticals Private Limited.
The legal entities of Shivaxy currently have 2 directors, including Kumari Aarti, Gaurav Sharma.